Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.38
Delayed Data
As of Aug 18
 0.00 / 0.00%
Today’s Change
0.20
Today|||52-Week Range
0.50
0.00%
Year-to-Date
Pfizer's (PFE) Besponsa Gets FDA Nod with a Boxed Warning
Aug 18 / Zacks.com - Paid Partner Content
Pacira Pharmaceuticals Focuses on Exparel's Label Expansion
Aug 14 / Zacks.com - Paid Partner Content
European Pharma Companies Slip on MS Pricing Probe
Aug 18 / TheStreet.com - Paid Partner Content
Novo Nordisk (NVO) Beats on Q2 Earnings, Revenues Miss
Aug 11 / Zacks.com - Paid Partner Content
Seattle Genetics' Adcetris Granted Priority Review by FDA
Aug 17 / Zacks.com - Paid Partner Content
Forget Teva (TEVA), Buy These 4 Drug Stocks Instead
Aug 11 / Zacks.com - Paid Partner Content
Mylan Finalizes $465 Million EpiPen Settlement With DoJ
Aug 17 / TheStreet.com - Paid Partner Content
Alnylam (ALNY) Q2 Loss Narrower than Expected, Sales Miss
Aug 10 / Zacks.com - Paid Partner Content
Regeneron's (REGN) RSV Drug Suptavumab Fails NURSERY Trial
Aug 16 / Zacks.com - Paid Partner Content
Intrexon (XON) Q2 Loss Narrower than Expected, Revenues Miss
Aug 10 / Zacks.com - Paid Partner Content
Spectrum (SPPI) Initiates Phase II Study for Cancer Drug
Aug 16 / Zacks.com - Paid Partner Content
Catalyst (CPRX) Posts Narrower than Expected Loss in Q2
Aug 10 / Zacks.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Forget Bayer, Buy These 3 Drug Stocks Instead
Aug 08 / Zacks.com - Paid Partner Content
Cullen Capital Management, LLC Buys Globaltrans Investment PLC, Smurfit Kappa Group P...
Aug 16 / GuruFocus News - Paid Partner Content
Takeover talk; Watching Venezuela; Earnings season rolls on
Jul 31 / CNNMoney.com
Are Amgen's New Drugs Doing Well Enough to Drive Sales?
Aug 15 / Zacks.com - Paid Partner Content